<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND PURPOSE: Purinergic <z:chebi fb="0" ids="33838">nucleoside</z:chebi> <z:chebi fb="0" ids="17596">inosine</z:chebi> elicits protection and regeneration during various injuries </plain></SENT>
<SENT sid="1" pm="."><plain>The purpose of this study was to examine the protective effects of <z:chebi fb="0" ids="17596">inosine</z:chebi> against <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Adult Sprague-Dawley rats were anesthetized </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="17596">Inosine</z:chebi>, hypoxathine, or vehicle was administered intracerebroventricularly before transient right middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAo) </plain></SENT>
<SENT sid="4" pm="."><plain>Animals were placed in behavioral chambers 2 days to 2 weeks after MCAo and then euthanized for tri-<z:chebi fb="1" ids="30396">phenyl</z:chebi>-tetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="6" ids="14321,29987">Glutamate</z:chebi> release was measured by microdialysis/high-performance liquid chromatography, and single-unit action potentials were recorded from neurons in the parietal cortex </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:hpo ids='HP_0001297'>Stroke</z:hpo> animals receiving <z:chebi fb="0" ids="17596">inosine</z:chebi> pretreatment demonstrated a higher level of locomotor activity and less <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Intracerebroventricular administration of the same dose of <z:chebi fb="0" ids="17368">hypoxanthine</z:chebi> did not confer protection </plain></SENT>
<SENT sid="8" pm="."><plain>Coadministration of selective A3 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> 3-ethyl-5-<z:chebi fb="0" ids="22744">benzyl</z:chebi>-2-<z:chebi fb="36" ids="29309">methyl</z:chebi>-4-phenylethynyl-6-<z:chebi fb="1" ids="30396">phenyl</z:chebi>-1, 4-(+/-)-<z:chebi fb="0" ids="50075">dihydropyridine</z:chebi>-3,5-<z:chebi fb="0" ids="28965">dicarboxylate</z:chebi> (MRS1191) significantly reduced <z:chebi fb="0" ids="17596">inosine</z:chebi>-mediated protection </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="0" ids="17596">Inosine</z:chebi> did not alter basal <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> release, nor did it reduce <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>-evoked <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> overflow from cerebral cortex </plain></SENT>
<SENT sid="10" pm="."><plain>However, <z:chebi fb="0" ids="17596">inosine</z:chebi> antagonized <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>-induced electrophysiological excitation in cerebral cortical neurons </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSIONS: <z:chebi fb="0" ids="17596">Inosine</z:chebi> inhibits <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> postsynaptic responses and reduces <z:e sem="disease" ids="C0007785" disease_type="Disease or Syndrome" abbrv="">cerebral infarction</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Its protective effect against <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion-related insults may involve activation of <z:chebi fb="3" ids="16335">adenosine</z:chebi> A3 receptors </plain></SENT>
</text></document>